Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 2
2001 1
2004 1
2005 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Involvement of GSK-3beta in TWEAK-mediated NF-kappaB activation.
De Ketelaere A, Vermeulen L, Vialard J, Van De Weyer I, Van Wauwe J, Haegeman G, Moelans I. De Ketelaere A, et al. Among authors: van de weyer i. FEBS Lett. 2004 May 21;566(1-3):60-4. doi: 10.1016/j.febslet.2004.04.041. FEBS Lett. 2004. PMID: 15147869 Free article.
Human Mus81-associated endonuclease cleaves Holliday junctions in vitro.
Chen XB, Melchionna R, Denis CM, Gaillard PHL, Blasina A, Van de Weyer I, Boddy MN, Russell P, Vialard J, McGowan CH. Chen XB, et al. Among authors: van de weyer i. Mol Cell. 2001 Nov;8(5):1117-27. doi: 10.1016/s1097-2765(01)00375-6. Mol Cell. 2001. PMID: 11741546 Free article.
p53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2.
Aliouat-Denis CM, Dendouga N, Van den Wyngaert I, Goehlmann H, Steller U, van de Weyer I, Van Slycken N, Andries L, Kass S, Luyten W, Janicot M, Vialard JE. Aliouat-Denis CM, et al. Among authors: van de weyer i. Mol Cancer Res. 2005 Nov;3(11):627-34. doi: 10.1158/1541-7786.MCR-05-0121. Mol Cancer Res. 2005. PMID: 16317088
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE, Gommeren W, Heylen L, Luyten WH, Van de Weyer I, Vanhoenacker P, Haegeman G, Schotte A, Van Gompel P, Wouters R, Lesage AS. Leysen JE, et al. Among authors: van de weyer i. Mol Pharmacol. 1996 Dec;50(6):1567-80. Mol Pharmacol. 1996. PMID: 8967979